The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen

Journal of Urology

Volumn 169, Issue 2, 2003, Pages 589-591

  Carver, Brett S ^a   Bozeman, Caleb B ^a   Williams, B J ^a   Venable, Dennis D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

National Institutes of Health (U.S.); Prostate specific antigen, mass screening; Prostatic neoplasms; Prostatitis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; BLOOD LEVEL; CANCER SCREENING; DISEASE CLASSIFICATION; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; ORGAN SIZE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SECRETION; PROSTATITIS; SYMPTOMATOLOGY;

EID: 0037304491     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)63959-6     Document Type: Article

References (13)

1. Nickel, J. C., Nyberg, L. M. and Hennenfent, M.: Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology, 54: 229, 1999
2. Moon, T. D.: Questionnaire survey of urologists and primary care physicians' diagnostics and treatment practices for prostatitis. Urology, 50: 543, 1997
3. McNaughton Collins, M., Strafford, R. S., O'Leary, M. P. and Barry, M. J.: How common is prostatitis? A national survey of physician visits. J Urol, 159: 1224, 1998
4. Roberts, R. O., Lieber, M. M., Rhodes, T., Girman, C. J., Bostwick, D. G. and Jacobsen, S. J.: Prevalence of a physicianassigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology, 51: 578, 1998
5. Nadler, R. B., Humphrey, P. A., Smith, D. S., Catalona, W. J. and Ratliff, T. L.: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol, 154: 407, 1995
6. Hasui, Y., Marutsuka, K., Asada, Y., Ide, H., Nishi, S. and Osada, Y.: Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate, 25: 91, 1994
7. Potts, J. M.: Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol, 164: 1550, 2000
8. Bozeman, C. B., Carver, B. S., Eastham, J. A. and Venable, D. D.: Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol, 167: 1723, 2002
9. Meares, E. M., Jr.: Prostatitis. Med Clin North Am, 75: 405, 1991
10. McNaughton Collins, M., Meigs, J. B., Barry, M. J., Corkery, E. W., Giovannucci, E. and Kawachi, I.: Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol, 167: 1363, 2002
11. Abdalla, I., Ray, P., Ray, V., Vaida, F. and Vijayakumar, S.: Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer. Urology, 51: 300, 1998
12. Henderson, R. J., Eastham, J. A., Culkin, D. J., Kattan, M. W., Whatley, T., Mata, J. et al: Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. J Natl Cancer Inst, 89: 134, 1997
13. True, L. D. Berger, R. E., Rothman, I., Ross, S. O. and Krieger, J. N.: Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome a prospective biopsy study. J Urol, 162: 2014, 1999